Brief: Infinity Pharmaceuticals Posts FY Loss Of $0.50 Per Share
March 28 (Reuters) - Infinity Pharmaceuticals Inc
INFI.O :
* INFINITY PHARMACEUTICALS INC FY LOSS PER SHARE $0.50
* INFINITY PHARMACEUTICALS REPORTS FULL YEAR 2022 FINANCIAL
RESULTS
* INFINITY PHARMACEUTICALS INC - ENDED 2022 WITH TOTAL CASH
AND
CASH EQUIVALENTS OF $38.3 MILLION
Source text for Eikon: ID:nBw7qBqCza
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX